Kristen Alexander - Feb 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Finance and Accounting
Signature
/s/ Kristen L. Alexander
Stock symbol
LXRX
Transactions as of
Feb 28, 2023
Transactions value $
-$11,566
Form type
4
Date filed
3/1/2023, 03:56 PM
Previous filing
Feb 13, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +5.4K +31.83% 22.4K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +2.7K +12.07% 25.1K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +10.6K +42.36% 35.7K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Tax liability -$11.6K -5.33K -14.94% $2.17 30.4K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -5.4K -100% 0 Feb 28, 2023 Common Stock 5.4K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -2.7K -50% 2.7K Feb 28, 2023 Common Stock 2.7K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -10.6K -33.33% 21.2K Feb 28, 2023 Common Stock 10.6K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.